Is it more beneficial for appetite and weight management to exercise once or twice a day?

ISRCTN ISRCTN48264634
DOI https://doi.org/10.1186/ISRCTN48264634
Secondary identifying numbers LRM-1089
Submission date
07/12/2018
Registration date
11/12/2018
Last edited
16/02/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
There is a growing amount of literature committed to understanding if being more active will have beneficial effect on health. However, less is known on whether performing exercise twice a day is more beneficial than exercising once when matched for workload. Therefore, the aim of this study is to identify if workload matched exercise split over the day, will result in possible changes in gastrointestinal function, metabolic responses and appetite.

Who can participate ?
Healthy males (age 18-40 years; body mass index <29.9 kg/m2; non-smokers, no history of GI symptoms not consuming prescription medication and subsequently be physically active, in order to complete the trials.

What are the possible benefits and risks of participating?
1. Full fitness assessment
2. Information about the participants diet
3. Knowledge about how gastric emptying may affect exercise
4. Experience within a research laboratory

What does the study involve?
The study involves two non-consecutive test days in a randomised order. After a 24 hour standardisation period and overnight fast. Participants come to the laboratory and exercise; either split over the day (two, 30min cycles) or a one-off bout (60-min cycle) before consuming a milk-shake and a standardised semi-solid meal. Throughout the trial, measurements of subjective feelings of appetite, gastric emptying rate, substrate utilisation and 24-hour energy intake. Blood samples will also be taken regularly throughout the trials.

Where is the study run from?
Manchester Metropolitan University , Manchester (UK)

Who is funding the study?
Manchester Metropolitan university

When is the study starting and how long is it expected to run for?
December 2018 to September 2019

Who is the Main Contact?
Mr Lewis Mattin
lewis.mattin@stu.mmu.ac.uk

Contact information

Dr Gethin Evans
Scientific

School of Healthcare Science
Manchester Metropolitan University
Chester Street
Manchester
M1 5GD
United Kingdom

Phone +44 (0)1612471208
Email gethin.evans@mmu.ac.uk
Mr Lewis Mattin
Public

School of Healthcare Science
Manchester Metropolitan University
Chester Street
Manchester
M1 5GD
United Kingdom

Phone +44 (0)1612471215
Email lewis.mattin@stu.mmu.ac.uk

Study information

Study designInterventional, repeated measures with randomised crossover
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Other
Study typeOther
Participant information sheet Not available in web format please use contact details to request a participants information sheet
Scientific titleThe effect of exercising once vs. twice a day on gastrointestinal function, metabolic responses and appetite in healthy males: a randomised cross over trial.
Study acronymSplit exercise
Study hypothesis1. Exercising twice a day will result in differences in gastric emptying rate and metabolic responses compared to a single workload-matched bout of exercise.
2. Exercising twice a day will result in differences in appetite and gut hormone responses compared to a single workload-matched bout of exercise.
Ethics approval(s)The Faculty of Science and Engineering Research Ethics and Governance Committee at Manchester Metropolitan University, 11/2018, ref. 1089
ConditionObesity
InterventionParticipants will complete two 7h experimental trials in a randomised cross-over design, where each participant will complete both trial arms; exercise once and twice a day separated by a minimum of 7 days. One trial will consist of a one off 60-min cycle at 70% peak maximal oxygen uptake. After completion of this single bout of exercise, participants will ingest a milkshake containing 30% of their estimated energy expenditure through the trial. Following a rest period the remaining 70% of their estimated energy expenditure through the trial will be provide as a semi-solid meal. The second trial will consist of a 30-min cycle before participants will ingest a milkshake followed by the same rest period before completing the remaining 30-min cycle and ingestion of a semi-solid meal. There will be no follow up session apart from all participant will record 24-h food intake following both trials.
Intervention typeBehavioural
Primary outcome measure1. Gastric emptying rate of a semi-solid meal will be measured using the 13C breath test . Breath samples will be collected at baseline and every 15min for a two-hour period.
2. Circulating levels of key gut hormones and metabolic markers. Blood samples will be collected at baseline, pre-milkshake, 1h-post milkshake, 2h-post milkshake, pre-semi-solid meal ingestion, 1-h post meal ingestion and 2h post meal ingestion
3. Substrate oxidation will be measured using a breath-by breath gas analyser at rest, during exercise sessions and every 30 min post food ingestion for 2h
4. Visual analogue scales will be used to measure subjective sensations of appetite at rest, pre-meal ingestion and every 30min post food ingestion for 2h.
5. 24h post trial energy intake using weighed food intake dietary record
Secondary outcome measures1. Ratings of perceived exertion using the Borg scale and heart rate will be recorded pre exercise and every 15min during exercise
Overall study start date26/07/2018
Overall study end date30/08/2019

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
Upper age limit40 Years
SexMale
Target number of participants14 participants
Total final enrolment16
Participant inclusion criteria1. Healthy males
2. Age between 18-40 years
3. Body mass index = <29.9 kg/m2
4. Non-smokers
5. No history of GI symptoms
6. Not consuming prescription medication, or no other relevant medical conditions assessed by a medical screening questionnaire.
7. Subsequently be physically active, in order to complete the trials.
Participant exclusion criteria1. Lactose Intolerant
2. Vegan
Recruitment start date17/12/2018
Recruitment end date10/04/2019

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Manchester Metropolitan University
John Dalton Building
School of Healthcare Science
Chester Street
Manchester
M1 5GD
United Kingdom

Sponsor information

Manchester Metropolitan University
University/education

School of Healthcare Science
Faculty of Sciences and Engineering
Chester Street
Manchester
M1 5GD
England
United Kingdom

Phone 01612472818
Email Justine.Daniel@mmu.ac.uk
ROR logo "ROR" https://ror.org/02hstj355

Funders

Funder type

University/education

Manchester Metropolitan University
Private sector organisation / Universities (academic only)
Alternative name(s)
MMU
Location
United Kingdom

Results and Publications

Intention to publish date30/08/2020
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned communication of results at a scientific conference .
Planned publication in a high impact peer reviewed journal within 12 months of the completion of the study
IPD sharing planParticipant level data is not expected to be available as this complies with the conditions of the ethical approval grated for this study.

Editorial Notes

16/02/2021: Internal review.
05/09/2019: The following changes have been made:
1. The recruitment end date has been changed from 31/08/2019 to 10/04/2019.
2. The overall trial end date has been changed from 30/09/2019 to 30/08/2019.
3. The intention to publish date was changed from 20/05/2020 to 30/08/2020.
4. The final enrolment number was added.
18/12/2018: Internal review.